Citi Trends Inc (CTRN) Drops 7.96% on February 08

Equities Staff |

Citi Trends Inc (CTRN) was one of the Russell 2000's biggest losers for Monday February 08 as the stock slid 7.96% to $16.43, a loss of $-1.42 per share. Starting at an opening price of $17.17 a share, the stock traded between $16.21 and $17.26 over the course of the trading day. Volume was 79,966 shares over 920 trades, against an average daily volume of 153,848 shares and a total float of 15.17 million.

The losses send Citi Trends Inc down to a market cap of $249.29 million. In the last year, Citi Trends Inc has traded between $28.69 and $17.27, and its 50-day SMA is currently $20.11 and 200-day SMA is $23.47.

The stock has a P/E Ratio of 16.2.

Citi Trends Inc is a value-priced retailer of urban fashion apparel and accessories for the entire family. The Company's merchandise offerings are designed to appeal to the preferences of fashion conscious consumers, particularly African-Americans.

Citi Trends Inc is based out of Savannah, GA and has some 5,200 employees. Its CEO is Jason T. Mazzola.

For a complete fundamental analysis analysis of Citi Trends Inc, check out Equities.com’s Stock Valuation Analysis report for CTRN. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Private Markets

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…